Gut Microbiome Composition in Lynch Syndrome With and Without History of Colorectal Neoplasia and Non-Lynch Controls.
Colorectal cancer (CRC)
Colorectal neoplasia (CRN)
DNA mismatch repair (MMR)
Lynch syndrome (LS)
Microbiome
Journal
Journal of gastrointestinal cancer
ISSN: 1941-6636
Titre abrégé: J Gastrointest Cancer
Pays: United States
ID NLM: 101479627
Informations de publication
Date de publication:
13 Jun 2023
13 Jun 2023
Historique:
accepted:
24
02
2023
medline:
13
6
2023
pubmed:
13
6
2023
entrez:
13
6
2023
Statut:
aheadofprint
Résumé
While Lynch syndrome (LS) is a highly penetrant colorectal cancer (CRC) syndrome, there is considerable variation in penetrance; few studies have investigated the association between microbiome and CRC risk in LS. We analyzed the microbiome composition among individuals with LS with and without personal history of colorectal neoplasia (CRN) and non-LS controls. We sequenced the V4 region of the 16S rRNA gene from the stool of 46 individuals with LS and 53 individuals without LS. We characterized within community and in between community microbiome variation, compared taxon abundance, and built machine learning models to investigate the differences in microbiome. There was no difference within or between community variations among LS groups, but there was a statistically significant difference in both within and between community variation comparing LS to non-LS. Streptococcus and Actinomyces were differentially enriched in LS-CRC compared to LS-without CRN. There were numerous differences in taxa abundance comparing LS to non-LS; notably, Veillonella was enriched and Faecalibacterium and Romboutsia were depleted in LS. Finally, machine learning models classifying LS from non-LS controls and LS-CRC from LS-without CRN performed moderately well. Differences in microbiome composition between LS and non-LS may suggest a microbiome pattern unique to LS formed by underlying differences in epithelial biology and immunology. We found specific taxa differences among LS groups, which may be due to underlying anatomy. Larger prospective studies following for CRN diagnosis and microbiome composition changes are needed to determine if microbiome composition contributes to CRN development in patients with LS.
Sections du résumé
BACKGROUND
BACKGROUND
While Lynch syndrome (LS) is a highly penetrant colorectal cancer (CRC) syndrome, there is considerable variation in penetrance; few studies have investigated the association between microbiome and CRC risk in LS. We analyzed the microbiome composition among individuals with LS with and without personal history of colorectal neoplasia (CRN) and non-LS controls.
METHODS
METHODS
We sequenced the V4 region of the 16S rRNA gene from the stool of 46 individuals with LS and 53 individuals without LS. We characterized within community and in between community microbiome variation, compared taxon abundance, and built machine learning models to investigate the differences in microbiome.
RESULTS
RESULTS
There was no difference within or between community variations among LS groups, but there was a statistically significant difference in both within and between community variation comparing LS to non-LS. Streptococcus and Actinomyces were differentially enriched in LS-CRC compared to LS-without CRN. There were numerous differences in taxa abundance comparing LS to non-LS; notably, Veillonella was enriched and Faecalibacterium and Romboutsia were depleted in LS. Finally, machine learning models classifying LS from non-LS controls and LS-CRC from LS-without CRN performed moderately well.
CONCLUSIONS
CONCLUSIONS
Differences in microbiome composition between LS and non-LS may suggest a microbiome pattern unique to LS formed by underlying differences in epithelial biology and immunology. We found specific taxa differences among LS groups, which may be due to underlying anatomy. Larger prospective studies following for CRN diagnosis and microbiome composition changes are needed to determine if microbiome composition contributes to CRN development in patients with LS.
Identifiants
pubmed: 37310549
doi: 10.1007/s12029-023-00925-4
pii: 10.1007/s12029-023-00925-4
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Møller P, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66(3):464–72. https://doi.org/10.1136/gutjnl-2015-309675 .
doi: 10.1136/gutjnl-2015-309675
pubmed: 26657901
Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10(8):575–82. https://doi.org/10.1038/nrmicro2819 .
doi: 10.1038/nrmicro2819
pubmed: 22728587
Wu S, et al. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med. 2009;15(9):1016–22. https://doi.org/10.1038/nm.2015 .
doi: 10.1038/nm.2015
pubmed: 19701202
pmcid: 3034219
Dejea CM, et al. Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria. Science. 2018;359(6375):592–7. https://doi.org/10.1126/science.aah3648 .
doi: 10.1126/science.aah3648
pubmed: 29420293
pmcid: 5881113
Arthur JC, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–3. https://doi.org/10.1126/science.1224820 .
doi: 10.1126/science.1224820
pubmed: 22903521
pmcid: 3645302
De Almeida CV, de Camargo MR, Russo E, Amedei A. Role of diet and gut microbiota on colorectal cancer immunomodulation. World J Gastroenterol. 2019;25(2):151–62. https://doi.org/10.3748/wjg.v25.i2.151 .
doi: 10.3748/wjg.v25.i2.151
pubmed: 30670906
pmcid: 6337022
Zackular JP, Rogers MAM, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res Phila Pa. 2014;7(11):1112–21. https://doi.org/10.1158/1940-6207.CAPR-14-0129 .
doi: 10.1158/1940-6207.CAPR-14-0129
Drewes JL, et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia. NPJ Biofilms Microbiomes. 2017;3:34. https://doi.org/10.1038/s41522-017-0040-3 .
doi: 10.1038/s41522-017-0040-3
pubmed: 29214046
pmcid: 5707393
Flemer B, et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut. 2017;66(4):633–43. https://doi.org/10.1136/gutjnl-2015-309595 .
doi: 10.1136/gutjnl-2015-309595
pubmed: 26992426
Brim H, et al. Microbiome analysis of stool samples from African Americans with colon polyps. PloS One. 2013;8(12):e81352. https://doi.org/10.1371/journal.pone.0081352 .
Lu Y, et al. Mucosal adherent bacterial dysbiosis in patients with colorectal adenomas. Sci Rep. 2016;6(26337). https://doi.org/10.1038/srep26337 .
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219–32. https://doi.org/10.1038/nri.2017.7 .
doi: 10.1038/nri.2017.7
pubmed: 28260787
Zhang Y, et al. Changes in gut microbiota and plasma inflammatory factors across the stages of colorectal tumorigenesis: a case-control study. BMC Microbiol. 2018;18(1):92. https://doi.org/10.1186/s12866-018-1232-6 .
doi: 10.1186/s12866-018-1232-6
pubmed: 30157754
pmcid: 6114884
Sze MA, Baxter NT, Ruffin MT, Rogers MAM, Schloss PD. Normalization of the microbiota in patients after treatment for colonic lesions. Microbiome. 2017;5(1):150. https://doi.org/10.1186/s40168-017-0366-3 .
doi: 10.1186/s40168-017-0366-3
pubmed: 29145893
pmcid: 5689185
Yan Y, et al. Structure of the mucosal and stool microbiome in Lynch syndrome. Cell Host Microbe. 2020;27(4):585–600. https://doi.org/10.1016/j.chom.2020.03.005 .
doi: 10.1016/j.chom.2020.03.005
pubmed: 32240601
pmcid: 7453618
Mori G, et al. Gut microbiota analysis in postoperative Lynch syndrome patients. Front Microbiol. 2019;10:1746. https://doi.org/10.3389/fmicb.2019.01746 .
doi: 10.3389/fmicb.2019.01746
pubmed: 31417532
pmcid: 6682596
Lu X, Kang Q, Jin P, Sheng J. The interactions between gut microbiota and Lynch syndrome. Clin Gastroenterol Hepatol. 2017;15(1):e48. https://doi.org/10.1016/j.cgh.2016.09.116 .
Ferrarese R, et al. Oral and fecal microbiota in Lynch syndrome. J Clin Med. 2020;9(9):E2735. https://doi.org/10.3390/jcm9092735 .
doi: 10.3390/jcm9092735
Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79(17):5112–20. https://doi.org/10.1128/AEM.01043-13 .
doi: 10.1128/AEM.01043-13
pubmed: 23793624
pmcid: 3753973
Schloss PD, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–41. https://doi.org/10.1128/AEM.01541-09 .
doi: 10.1128/AEM.01541-09
pubmed: 19801464
pmcid: 2786419
Pruesse E, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35(21):7188–96. https://doi.org/10.1093/nar/gkm864 .
doi: 10.1093/nar/gkm864
pubmed: 17947321
pmcid: 2175337
Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–7. https://doi.org/10.1128/AEM.00062-07 .
doi: 10.1128/AEM.00062-07
pubmed: 17586664
pmcid: 1950982
Westcott SL, Schloss PD. OptiClust, an improved method for assigning amplicon-based sequence data to operational taxonomic units. mSphere 2017;2(2). https://doi.org/10.1128/mSphereDirect.00073-17 .
Martin BD, Witten D, Willis AD. Modeling microbial abundances and dysbiosis with beta-binomial regression. Ann Appl Stat. 2020;14(1):94–115. https://doi.org/10.1214/19-aoas1283 .
doi: 10.1214/19-aoas1283
pubmed: 32983313
pmcid: 7514055
Topçuoğlu BD, Lesniak NA, Ruffin MT, Wiens J, Schloss PD. A framework for effective application of machine learning to microbiome-based classification problems. mBio. 11(3):e00434–20. https://doi.org/10.1128/mBio.00434-20 .
Andres-Franch M, et al. Streptococcus gallolyticus infection in colorectal cancer and association with biological and clinical factors. PloS One. 2017;12(3):e0174305. https://doi.org/10.1371/journal.pone.0174305 .
Yu L, et al. A systematic review of microbial markers for risk prediction of colorectal neoplasia. Br J Cancer. 2022;1–11. https://doi.org/10.1038/s41416-022-01740-7 .
Mangifesta M, et al. Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer. Sci Rep. 2018;8(1):13974. https://doi.org/10.1038/s41598-018-32413-2 .
doi: 10.1038/s41598-018-32413-2
pubmed: 30228361
pmcid: 6143603
Gonzalez A, Kapila N, Melendez-Rosado J, Liang H, Castro-Pavia F. An evaluation of the fecal microbiome in Lynch syndrome. J Gastrointest Cancer. 2021;52(1):365–8. https://doi.org/10.1007/s12029-021-00588-z .
doi: 10.1007/s12029-021-00588-z
pubmed: 33492618
Belcheva A, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 2014;158(2):288–99. https://doi.org/10.1016/j.cell.2014.04.051 .
doi: 10.1016/j.cell.2014.04.051
pubmed: 25036629
Mathers JC, et al. Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol. 2012;13(12):1242–9. https://doi.org/10.1016/S1470-2045(12)70475-8 .
doi: 10.1016/S1470-2045(12)70475-8
pubmed: 23140761
Pieters W, et al. Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model. Gut Microbes. 2022;14(1):2035660. https://doi.org/10.1080/19490976.2022.2035660 .
doi: 10.1080/19490976.2022.2035660
pubmed: 35188867
pmcid: 8865281